arrow
Back
P

Pablo García‐Pavía

hospital universitario puerta de hierro majadahonda

72H-index
561Paper Count
2.1WCitation Count
Published Papers 251
Publication Date
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy
err2026-08-30
err0
errOAAI
errYasuhiro Hamatani; Brian L. Claggett; Sarah A.M. Cuddy; Nitasha Sarswat; Joban Vaishnav; Martha Grogan; Mathew S. Maurer; Ronald M. Witteles; Esther Gonzalez-Lopez; Pablo Garcia-Pavia; Farooq H. Sheikh; Brian M. Drachman; Alisa Kosheleff; Sameer Bansilal; Julian D. Gillmore; Marianna Fontana; Scott D. Solomon
errShare
errSave
Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial
err2026-08-30
err0
errOAAI
errPablo García-Pavía; Francesco Cappelli; Margot K. Davis; Marianna Fontana; Julian D. Gillmore; Mazen Hanna; Ahmad Masri; Laura Obici; Scott D. Solomon; Brett W. Sperry; Nobuhiro Tahara; Márcia Waddington-Cruz; Kurt Boman; Sarah A. M. Cuddy; Philippe Debonnaire; Nowell M. Fine; Piotr Podolec; Ali Yilmaz; Tom Conrad; Qingqing Yang; Brian L. Claggett; Jersey Chen; Sotirios Tsimikas; Mathew S. Maurer
errShare
errSave
Impact of Tafamidis on Transthyretin Concentration and Its Relation to All-Cause Mortality in Patients with Transthyretin Amyloid Cardiomyopathy: An Analysis from ATTR-ACT
err2026-08-27
err0
errOAAI
errMathew S. Maurer; Perry Elliott; Jeffery W. Kelly; Mazen Hanna; Evan T. Powers; Steve Riley; Rong Wang; Pablo Garcia-Pavia
errShare
errSave
errShare
errSave
Functional Stability Measured by Changes in the 6-min Walk Test in Patients Treated with Tafamidis Versus Placebo: Post hoc Analysis from ATTR-ACT
err2026-08-27
err0
errOAAI
errRonald Witteles; Mazen A. Hanna; Martha Grogan; Perry Elliott; Ronnie Wang; Pablo Garcia-Pavia
errShare
errSave
Rationale and Design of ACO-REAL: A Real-World Non-Interventional Study of Acoramidis in Routine Clinical Practice
err2026-07-31
err0
errOAAI
errMarianna Fontana; Francesco Cappelli; Julian D. Gillmore; Laura Obici; Fabian aus dem Siepen; Philippe Debonnaire; Esther Gonzalez-Lopez; Marcel Schulze; Kai Vogtländer; Antonio Ciaccia; Martin Merz; Pablo Garcia-Pavia
errShare
errSave
Guidelines for the management of hereditary ATTR amyloidosis 2026
err2026-07-09
err0
PREAI
errYoshiki Sekijima; Mitsuharu Ueda; John L. Berk; Laura Obici; Ronald M. Witteles; Violaine Planté-Bordeneuve; Markus Weiler; Marianna Fontana; Márcia Waddington Cruz; Teresa Coelho; Bo-Göran Ericzon; Pablo Garcia-Pavia; João Beirão; Jonas Wixner; Luísa Lobato; Yukio Ando; Giampaolo Merlini; Mathew S. Maurer
errShare
errSave
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis
err2026-06-16
err0
errOAAI
errDaniel P. Judge; Alan X. Ji; Isabella A. Graef; Martha Grogan; Prem Soman; Francesco Cappelli; Marianna Fontana; Ahmad Masri; Julian D. Gillmore; Pablo Garcia-Pavia; Xiaofan Cao; Jonathan C. Fox; Uma Sinha
errShare
errSave
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis
err2026-05-27
err0
errOAAI
errMarianna Fontana; Vincent Algalarrondo; Pablo Garcia-Pavia; Mathew S. Maurer; Julian D. Gillmore; Francesco Cappelli; Kiranmai Kolachana; Xiuqing Gao; Satyawan Jadhav; Nitin Mehrotra; Gabriel Robbie; Prajakta Badri
errShare
errSave
Epidemiology of non-ischaemic dilated cardiomyopathy
err2026-05-18
err0
PREAI
errNoemí Ramos-López; Fernando Domínguez; Juan Pablo Ochoa; Enrique Lara-Pezzi; Pablo Garcia-Pavia
errShare
errSave
Cascade genetic screening in hereditary transthyretin amyloidosis: when early diagnosis becomes survival
err2026-04-16
err0
PREAI
errNerea Mora-Ayestarán; Esther Gonzalez-Lopez; Pablo Garcia-Pavia
errShare
errSave
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy
err2025-12-01
err0
PREAI
errGillmore, Julian D.; Judge, Daniel P.; Cappelli, Francesco; Fontana, Marianna; Garcia-Pavia, Pablo; Gibbs, Simon; Grogan, Martha; Hanna, Mazen; Hoffman, James; Masri, Ahmad; Maurer, Mathew S.; Nativi-Nicolau, Jose; Obici, Laura; Poulsen, Steen Hvitfeldt; Rockhold, Frank; Shah, Keyur B.; Soman, Prem; Garg, Jyotsna; Chiswell, Karen; Xu, Haolin; Cao, Xiaofan; Lystig, Ted; Sinha, Uma; Fox, Jonathan C.
errShare
errSave
Myosin inhibition in obstructive HCM: A new starting point for therapy
err2025-11-25
err0
PREAI
errNoemi Ramos; Fernando Domínguez; Pablo Garcia-Pavia
errShare
errSave
Detection of Titin-Associated Electrocardiography Features in Dilated Cardiomyopathy Using Conventional and Deep Neural Network Analysis
err2025-11-24
err0
errOAAI
errAstrid B.M. Heymans; Rutger R. van de Leur; Ping Wang; Esther González-López; Max F.G.H.M. Venner; Nina J. Beelen; Steven A. Muller; Nerea Mora-Ayestarán; Noemi Ramos; Isa M.E. Faassen; Sophie L.V.M. Stroeks; Miriam Soria; Saskia N. van der Crabben; Rachel M.A. ter Bekke; René van Es; Kevin Vernooy; Anneline S.J.M. te Riele; Pablo García-Pavía; Stephane R.B. Heymans; Job A.J. Verdonschot
errShare
errSave
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multi-Domain, Patient-Level Analysis of the MAPLE-HCM Trial
errJACC
IF0
err2025-11-18
err0
errOAAI
errAndrew Wang; Pablo Garcia-Pavia; Ahmad Masri; Bela Merkely; Michael E. Nassif; Maria Luisa Peña-Peña; Roberto Barriales-Villa; Ozlem Bilen; Melissa Burroughs; Brian L. Claggett; Juan Pablo Costabel; Edileide de Barros Correia; Anne Dybro; Perry Elliott; Sheila M. Hegde; Ian J. Kulac; Neal K. Lakdawala; Gregory D. Lewis; Amy Mann; Ajith Nair
errShare
errSave
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy
errJACC
IF0
err2025-11-18
err0
errOAAI
errMichael E. Nassif; Pablo Garcia-Pavia; Ahmad Masri; Bela Merkely; Maria Luisa Peña-Peña; Roberto Barriales-Villa; Ozlem Bilen; Melissa Burroughs; Brian L. Claggett; Juan Pablo Costabel; Edileide de Barros Correia; Anne M. Dybro; Perry Elliott; Neal K. Lakdawala; Gregory D. Lewis; Amy Mann; Martin S. Maron; Zi Michael Miao; Ajith Nair; Steen H. Poulsen
errShare
errSave
Multicellular trajectories leading to subclinical diastolic dysfunction and HFpEF progression in cardiometabolic comorbidities
err2025-11-05
err0
errOAAI
errA Ausiello; L Lalaguna; M Lopez-Olaneta; P Rivas Daza; M Villalba-Orero; P Garcia-Pavia; D Pascual-Figal; E Lara-Pezzi
errShare
errSave
Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy
err2025-11-05
err0
errOAAI
errI Olivotto; P Garcia-Pavia; Z Tian; A T Owens; N K Lakdawala; G Balaratnam; Y Zhong; A Memaj; Y C Barrett; M Desai
errShare
errSave
Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial
err2025-10-29
err0
errOAAI
errAwais Sheikh; Zi Michael Miao; Brian Claggett; Pablo Garcia-Pavia; Francesco Cappelli; Emre Aldinc; Julian Gillmore; Scott D. Solomon; Marianna Fontana
errShare
errSave
Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CM
err2025-10-13
err0
errOAAI
errPablo Garcia-Pavia; Francisco Javier Haro del Moral; Francesco Cappelli; Nicolas Piriou; Roberto Barriales-Villa; Carmen Munteanu; Catherine Bahus; Denis Keohane; Pablo Mallaina; Emmanuel Itti; Thibaud Damy; Perry Elliott
errShare
errSave